Search Results

There are 15661 results for: content related to: KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma

  1. You have free access to this content
    KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue

    International Journal of Cancer

    Volume 133, Issue 1, July 2013, Pages: 130–141, Bianca Mostert, Yuqiu Jiang, Anieta M. Sieuwerts, Haiying Wang, Joan Bolt-de Vries, Katharina Biermann, Jaco Kraan, Zarina Lalmahomed, Anne van Galen, Vanja de Weerd, Petra van der Spoel, Raquel Ramírez-Moreno, Cornelis Verhoef, Jan N.M. IJzermans, Yixin Wang, Jan-Willem Gratama, John A. Foekens, Stefan Sleijfer and John W.M. Martens

    Version of Record online : 9 FEB 2013, DOI: 10.1002/ijc.27987

  2. Tumor Heterogeneity Revealed by KRAS, BRAF, and PIK3CA Pyrosequencing: KRAS and PIK3CA Intratumor Mutation Profile Differences and Their Therapeutic Implications

    Human Mutation

    Volume 35, Issue 3, March 2014, Pages: 329–340, Vivian Kosmidou, Eftychia Oikonomou, Margarita Vlassi, Spyros Avlonitis, Anastasia Katseli, Iraklis Tsipras, Despina Mourtzoukou, Georgios Kontogeorgos, Georgios Zografos and Alexander Pintzas

    Version of Record online : 15 JAN 2014, DOI: 10.1002/humu.22496

  3. Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 11, Issue 2, June 2015, Pages: 160–169, Brigette B Ma, Frankie Mo, Joanna H Tong, Ashley Wong, SC Cesar Wong, Wing M Ho, Cherry Wu, Polly WY Lam, KF Chan, Timothy SK Chan, Wilson MS Tsui, Alex KH Tsang, Mandy NS Fung, Anthony TC Chan and Ka Fai To

    Version of Record online : 13 APR 2015, DOI: 10.1111/ajco.12342

  4. You have free access to this content
    The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104-trial

    International Journal of Cancer

    Volume 131, Issue 4, 15 August 2012, Pages: 980–986, D.P. Modest, A. Jung, N. Moosmann, R.P. Laubender, C. Giessen, C. Schulz, M. Haas, J. Neumann, S. Boeck, T. Kirchner, V. Heinemann and S. Stintzing

    Version of Record online : 17 NOV 2011, DOI: 10.1002/ijc.26467

  5. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy

    Journal of Surgical Oncology

    Volume 106, Issue 2, 1 August 2012, Pages: 123–129, Hao-Wei Teng, Yu-Chung Huang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Jeng-Kai Jiang, Chueh-Chuan Yen, Anna Fen-Yau Li, Hsei-Wei Wang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Huann-Sheng Wang and Shung-Haur Yang

    Version of Record online : 13 FEB 2012, DOI: 10.1002/jso.23063

  6. You have free access to this content
    Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma

    Cancer

    Volume 118, Issue 24, 15 December 2012, Pages: 6243–6252, Jeffrey S. Rose, Derek S. Serna, Ludmila Katherine Martin, Xiaobai Li, Lynn M. Weatherby, Sherif Abdel-Misih, Weiqiang Zhao and Tanios Bekaii-Saab

    Version of Record online : 6 JUN 2012, DOI: 10.1002/cncr.27666

  7. You have full text access to this OnlineOpen article
    Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma

    Histopathology

    Volume 58, Issue 5, April 2011, Pages: 679–692, Karoliina Stefanius, Laura Ylitalo, Anne Tuomisto, Rami Kuivila, Tiina Kantola, Päivi Sirniö, Tuomo J Karttunen and Markus J Mäkinen

    Version of Record online : 4 APR 2011, DOI: 10.1111/j.1365-2559.2011.03821.x

  8. Comparison of Targeted Next-Generation Sequencing (NGS) and Real-Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin-Fixed, Paraffin-Embedded Tumor Material of Non-Small Cell Lung Carcinoma—Superiority of NGS

    Genes, Chromosomes and Cancer

    Volume 52, Issue 5, May 2013, Pages: 503–511, Katja Tuononen, Satu Mäki-Nevala, Virinder Kaur Sarhadi, Aino Wirtanen, Mikko Rönty, Kaisa Salmenkivi, Jenny M. Andrews, Aino I. Telaranta-Keerie, Sari Hannula, Sonja Lagström, Pekka Ellonen, Aija Knuuttila and Sakari Knuutila

    Version of Record online : 30 JAN 2013, DOI: 10.1002/gcc.22047

  9. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma

    The Journal of Pathology

    Volume 231, Issue 4, December 2013, Pages: 449–456, Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson and Kwong-Kwok Wong

    Version of Record online : 12 NOV 2013, DOI: 10.1002/path.4252

  10. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer

    Journal of Surgical Oncology

    Volume 110, Issue 4, September 15, 2014, Pages: 451–457, Chun-Chi Lin, Jen-Kou Lin, Tzu-Chen Lin, Wei-Shone Chen, Shung-Haur Yang, Huann-Sheng Wang, Yuan-Tzu Lan, Jeng-Kai Jiang, Muh-Hwa Yang and Shih-Ching Chang

    Version of Record online : 25 JUN 2014, DOI: 10.1002/jso.23675

  11. You have free access to this content
    Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas

    International Journal of Cancer

    Volume 131, Issue 8, 15 October 2012, Pages: 1790–1799, J. García-Solano, P. Conesa-Zamora, P. Carbonell, J. Trujillo-Santos, D. Torres-Moreno D, I. Pagán-Gómez, E. Rodríguez-Braun and M. Pérez-Guillermo

    Version of Record online : 14 MAR 2012, DOI: 10.1002/ijc.27454

  12. You have full text access to this OnlineOpen article
    Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer

    Histopathology

    Volume 49, Issue 2, August 2006, Pages: 121–131, J R Jass, K Baker, I Zlobec, T Higuchi, M Barker, D Buchanan and J Young

    Version of Record online : 5 JUN 2006, DOI: 10.1111/j.1365-2559.2006.02466.x

  13. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab

    British Journal of Surgery

    Volume 99, Issue 11, November 2012, Pages: 1575–1582, S. Stremitzer, J. Stift, B. Gruenberger, D. Tamandl, T. Aschacher, B. Wolf, F. Wrba and T. Gruenberger

    Version of Record online : 1 OCT 2012, DOI: 10.1002/bjs.8909

  14. Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants

    The Journal of Pathology

    Volume 232, Issue 1, January 2014, Pages: 16–22, Laura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, Russell Vang, Leslie Cope, Jette Junge, Susanne K Kjaer, Robert J Kurman and Ie-Ming Shih

    Version of Record online : 6 DEC 2013, DOI: 10.1002/path.4293

  15. You have full text access to this OnlineOpen article
    Not just gRASping at flaws: Finding vulnerabilities to develop novel therapies for treating KRAS mutant cancers

    Cancer Science

    Volume 105, Issue 5, May 2014, Pages: 499–505, Hiromichi Ebi, Anthony C. Faber, Jeffrey A. Engelman and Seiji Yano

    Version of Record online : 26 MAR 2014, DOI: 10.1111/cas.12383

  16. You have free access to this content
    KRAS and BRAF: drug targets and predictive biomarkers

    The Journal of Pathology

    Volume 223, Issue 2, January 2011, Pages: 220–230, Efsevia Vakiani and David B Solit

    Version of Record online : 28 OCT 2010, DOI: 10.1002/path.2796

  17. You have full text access to this OnlineOpen article
    Use of multivariate analysis to suggest a new molecular classification of colorectal cancer

    The Journal of Pathology

    Volume 229, Issue 3, February 2013, Pages: 441–448, Enric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, Daniel Rosmarin, Michal Presz, Haitao Wang, Hannah Pulker, Helen Lockstone, Tarjei Hveem, Treena Cranston, Havard Danielsen, Marco Novelli, Brian Davidson, Zheng-Zhou Xu, Peter Molloy, Elaine Johnstone, Christopher Holmes, Rachel Midgley, David Kerr, Oliver Sieber and Ian Tomlinson

    Version of Record online : 25 JAN 2013, DOI: 10.1002/path.4139

  18. You have full text access to this OnlineOpen article
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases

    International Journal of Cancer

    Volume 139, Issue 3, 1 August 2016, Pages: 647–656, Inger Marie Løes, Heike Immervoll, Halfdan Sorbye, Jon-Helge Angelsen, Arild Horn, Stian Knappskog and Per Eystein Lønning

    Version of Record online : 4 APR 2016, DOI: 10.1002/ijc.30089

  19. You have free access to this content
    Loss of heterozygosity of chromosome 12p does not correlate with KRAS mutation in non-small cell lung cancer

    International Journal of Cancer

    Volume 107, Issue 6, 20 December 2003, Pages: 962–969, Mika Uchiyama, Noriyasu Usami, Masashi Kondo, Shoichi Mori, Masao Ito, Genshi Ito, Hiromu Yoshioka, Munehisa Imaizumi, Yuichi Ueda, Masahide Takahashi, John D. Minna, Kaoru Shimokata and Yoshitaka Sekido

    Version of Record online : 18 SEP 2003, DOI: 10.1002/ijc.11493

  20. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 20, Issue 2, February 2013, Pages: 223–233, Yuzo Umeda, Takeshi Nagasaka, Yoshiko Mori, Hiroshi Sadamori, Dong-Sheng Sun, Susumu Shinoura, Ryuich Yoshida, Daisuke Satoh, Daisuke Nobuoka, Masashi Utsumi, Kazuhiro Yoshida, Takahito Yagi and Toshiyoshi Fujiwara

    Version of Record online : 21 JUL 2012, DOI: 10.1007/s00534-012-0531-9